Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction
2018 ◽
Vol 20
(11)
◽
pp. 1601-1610
◽
Keyword(s):
2016 ◽
Vol 57
(4)
◽
pp. 440-451
◽
Keyword(s):
2013 ◽
Vol 6
(3)
◽
pp. 563-571
◽
2019 ◽
Vol 21
(11)
◽
pp. 1426-1433
◽
2008 ◽
Vol 7
◽
pp. 53-54
Keyword(s):
2014 ◽
Vol 25
(8)
◽
pp. 741-749
◽
Keyword(s):
1994 ◽
Vol 350
(1)
◽
2004 ◽
Vol 29
(Sup 2)
◽
pp. 100
Keyword(s):
1999 ◽
Vol 369
(3)
◽
pp. 325-329
◽